Leonard L. Mazur - Apr 3, 2024 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Alexander M. Donaldson, by power of attorney
Stock symbol
CTXR
Transactions as of
Apr 3, 2024
Transactions value $
$0
Form type
4
Date filed
4/5/2024, 04:05 PM
Previous filing
Oct 12, 2023
Next filing
Aug 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTXR Common Stock 10.3M Apr 3, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Warrant to Purchase Common Stock Disposed to Issuer -1.17M -100% 0 Apr 3, 2024 Common Stock 1.17M $1.42 Direct F1
transaction CTXR Warrant to Purchase Common Stock Award +1.17M 1.17M Apr 3, 2024 Common Stock 1.17M $1.42 Direct F1
holding CTXR Stock Option (Right to Purchase Common Stock) 550K Apr 3, 2024 Common Stock 550K $0.70 Direct F2
holding CTXR Stock Option (Right to Purchase Common Stock) 550K Apr 3, 2024 Common Stock 550K $1.25 Direct F3
holding CTXR Stock Option (Right to Purchase Common Stock) 650K Apr 3, 2024 Common Stock 650K $2.04 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 300K Apr 3, 2024 Common Stock 300K $2.00 Direct F5
holding CTXR Stock Option (Right to Purchase Common Stock) 200K Apr 3, 2024 Common Stock 200K $1.01 Direct F6
holding CTXR Stock Option (Right to Purchase Common Stock) 175K Apr 3, 2024 Common Stock 175K $0.67 Direct F7
holding CTXR Warrant to Purchase Common Stock 2.23M Apr 3, 2024 Common Stock 2.23M $0.77 Direct F8
holding CTXR Stock Option (Right to Purchase Common Stock) 150K Apr 3, 2024 Common Stock 150K $1.62 Direct F9
holding CTXR Warrant to Purchase Common Stock 3.14M Apr 3, 2024 Common Stock 3.14M $1.15 Direct F8
holding CTXR Stock Option (Right to Purchase Common Stock) 220K Apr 3, 2024 Common Stock 220K $6.75 Direct F10
holding CTXR Stock Option (Right to Purchase Common Stock) 40K Apr 3, 2024 Common Stock 40K $3.45 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.
F2 The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F3 The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F4 The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date
F5 The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date
F6 The options vested in full on October 6, 2023.
F7 The options vested in full on October 8, 2022.
F8 The warrant is fully vested and exercisable immediately.
F9 The options vested in full on September 4, 2021
F10 The options vested in full on September 12, 2017.
F11 The options vested in full on September 13, 2020.